Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Oric Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 142
- 0 vs. Q1 2025
- Shares held
- 93.4M
- +14.2M (+17.9%) vs. Q1 2025
- Total value
- $947.6M
- +$505.6M (+114.4%) vs. Q1 2025
- New holders
- 35
- 43 more added
- Sold out
- 35
- 51 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 298,442 | $3.03M | 0.00% | +38,641+14.9% | Added |
| Superstring Capital Management LP | 344,922 | $3.50M | 4.36% | −474,272−57.9% | Reduced |
| Millennium Management LLC | 350,535 | $3.56M | 0.00% | +296,552+549.3% | Added |
| Adage Capital Partners GP, L.L.C. | 365,400 | $3.71M | 0.01% | +365,400 | New |
| Charles Schwab Investment Management Inc | 382,389 | $3.88M | 0.00% | −26,116−6.4% | Reduced |
| Sphera Funds Management Ltd. | 394,693 | $4.01M | 1.05% | +159,859+68.1% | Added |
| Morgan Stanley | 394,785 | $4.01M | 0.00% | +226,114+134.1% | Added |
| Northern Trust Corp | 400,954 | $4.07M | 0.00% | −145,792−26.7% | Reduced |
| Ally Bridge Group (NY) LLC | 485,629 | $4.93M | 4.10% | +485,629 | New |
| Goldman Sachs Group Inc | 489,637 | $4.97M | 0.00% | +194,853+66.1% | Added |
| Dimensional Fund Advisors LP | 714,866 | $7.26M | 0.00% | −12,964−1.8% | Reduced |
| OrbiMed Advisors LLC | 899,281 | $9.13M | 0.23% | +199,281+28.5% | Added |
| Eventide Asset Management, LLC | 951,433 | $9.66M | 0.17% | +951,433 | New |
| Euclidean Capital LLC | 989,410 | $10.0M | 3.28% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,007,575 | $10.2M | 0.53% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,042,558 | $10.6M | 0.00% | +19,768+1.9% | Added |
| Frazier Life Sciences Management, L.P. | 1,065,334 | $10.8M | 0.43% | −344,859−24.5% | Reduced |
| Geode Capital Management, LLC | 1,108,460 | $11.3M | 0.00% | −197,531−15.1% | Reduced |
| Integral Health Asset Management, LLC | 1,250,000 | $12.7M | 1.19% | +1,250,000 | New |
| ArrowMark Colorado Holdings LLC | 1,278,454 | $13.0M | 0.23% | −67,735−5.0% | Reduced |
| JPMorgan Chase & Co | 1,335,448 | $13.6M | 0.00% | +1,299,799+3,646.1% | Added |
| Citadel Advisors LLC | 1,402,768 | $14.2M | 0.01% | +890,879+174.0% | Added |
| EcoR1 Capital, LLC | 1,618,068 | $16.4M | 0.97% | −1,800,000−52.7% | Reduced |
| State Street Corp | 1,632,116 | $16.6M | 0.00% | −564,433−25.7% | Reduced |
| MPM Oncology Impact Management LP | 1,729,378 | $17.6M | 3.04% | +329,864+23.6% | Added |
| Balyasny Asset Management LLC | 1,777,744 | $18.0M | 0.04% | −229,528−11.4% | Reduced |
| Silverarc Capital Management, LLC | 1,800,829 | $18.3M | 3.74% | −259,411−12.6% | Reduced |
| First Turn Management, LLC | 2,009,923 | $20.4M | 3.81% | −17,507−0.9% | Reduced |
| FMR LLC | 2,470,057 | $25.1M | 0.00% | −10,363−0.4% | Reduced |
| Price T Rowe Associates Inc | 2,762,915 | $28.0M | 0.00% | +1,430,055+107.3% | Added |
| Point72 Asset Management, L.P. | 2,850,641 | $28.9M | 0.07% | +2,850,641 | New |
| Vanguard Group Inc | 3,124,693 | $31.7M | 0.00% | −91,194−2.8% | Reduced |
| Vivo Capital, LLC | 3,126,604 | $31.7M | 3.25% | +1,046,154+50.3% | Added |
| The Column Group LLC | 3,540,777 | $35.9M | 54.68% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,077,985 | $41.4M | 0.00% | −1,357,102−25.0% | Reduced |
| NEA Management Company, LLC | 4,118,621 | $41.8M | 3.15% | +1,923,076+87.6% | Added |
| Alkeon Capital Management LLC | 4,504,096 | $45.7M | 0.22% | +500,000+12.5% | Added |
| Sr One Capital Management, LP | 4,514,929 | $45.8M | 9.93% | +4,514,929 | New |
| Pfizer Inc | 5,376,344 | $54.6M | 9.47% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,572,700 | $66.7M | 0.19% | 00.0% | Unchanged |
| VR Adviser, LLC | 6,596,885 | $67.0M | 5.02% | +3,414,358+107.3% | Added |
| Nextech Invest, Ltd. | 7,162,637 | $72.7M | 13.76% | +1,876,923+35.5% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −1,732,571−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −509,179−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −426,902−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −255,000−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −203,006−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −76,990−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −76,093−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −68,400−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −47,695−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −40,934−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −40,934−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −30,163−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −19,915−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −19,523−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,077−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,983−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −16,469−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −15,844−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −15,691−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −13,662−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −12,626−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,088−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −8,324−100.0% | Sold out |
| KLP Kapitalforvaltning AS | 0 | $0 | 0.00% | −6,200−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −607−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −178−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |